Form DEFA14A Series Portfolios Trust
SCHEDULE 14A
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
| Filed by the Registrant | þ | |||||||||||||
| Filed by a Party other than the Registrant | o | |||||||||||||
| Check the appropriate box: | ||||||||||||||
| o | Preliminary Proxy Statement | |||||||||||||
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||||||||
| o | Definitive Joint Proxy Statement | |||||||||||||
| o | Definitive Additional Materials | |||||||||||||
| þ | Soliciting Material Under Rule 14a-12 | |||||||||||||
SERIES PORTFOLIO TRUST
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check the appropriate box): | ||||||||||||||
| þ | No fee required. | |||||||||||||
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. | |||||||||||||
| (1) | Title of each class of securities to which transaction applies: | |||||||||||||
| (2) | Aggregate number of securities to which transaction applies: | |||||||||||||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |||||||||||||
| (4) | Proposed maximum aggregate value of transaction: | |||||||||||||
| (5) | Total fee paid: | |||||||||||||
| o | Fee paid previously with preliminary materials: | |||||||||||||
| o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||||||||||||
| (1) | Amount Previously Paid: | |||||||||||||
| (2) | Form, Schedule or Registration Statement No.: | |||||||||||||
| (3) | Filing Party: | |||||||||||||
| (4) | Date Filed: | |||||||||||||
Unusual Whales Subversive Democratic Trading ETF
Unusual Whales Subversive Republican Trading ETF
(together, the “Target Funds”),
Each a series of Series Portfolios Trust
December 4, 2024
Dear Shareholder,
The Special Meeting of Shareholders of the above Target Funds has been adjourned until December 19, 2024. The overall vote response for both Funds has been positive. Greater than 84% of your fellow shareholders have voted FOR the Plan of Reorganization.
Shareholders in both Funds are primarily retail investors. Unless shareholders with smaller positions vote, it will be difficult to reach the vote requirement threshold. Your vote is critical. Please join your fellow shareholders by taking a few minutes to sign, date and mail the enclosed proxy card in the prepaid envelope or follow the instructions below to vote by telephone or internet.
Unfortunately, if the proposal does not pass, your Board will consider other possible courses of action, which may include liquidating a Target Fund that does not approve the Plan of Reorganization.
![]() | Vote by Phone by calling +1 (888) 372-8265 and speaking with a proxy voting specialist today. Our representatives are available weekdays from 10 a.m. to 11 p.m. Eastern time. You may also call the toll-free number on the enclosed card and follow the prompts. | ||||
| : | Vote by Internet by visiting the internet address on the enclosed card and following the instructions. | ||||
| * | Vote by Mail by completing, signing, and dating the enclosed card and returning it in the enclosed prepaid return envelope. | ||||
If you have any questions or need assistance in voting, please contact our proxy solicitor, Morrow Sodali Fund Solutions at +1 (888) 372-8265. Please note that a representative may call you to assist in voting.
| Sincerely, | ||
| /s/ Ryan L. Roell | ||
| RYAN L. ROELL | ||
PRESIDENT, SERIES PORTFOLIOS TRUST | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NINGJI Takes Centre Stage at KLCC, Strengthening Its Position as a Benchmark for Southeast Asian Expansion Through Five Key Localization Strategies
- AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma
- Crypto Update: MSCI Threatens $2B in Forced Selling While Pepeto Presale Captures What Large Caps Left Behind
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share